Selective macrophage ascorbate deficiency suppresses early atherosclerosis

Free Radical Biology and Medicine

Volumn 50, Issue 1, 2011, Pages 27-36

  Babaev, Vladimir R ^a   Whitesell, Richard R ^b   Li, Liying ^a   Linton, Macrae F ^a   Fazio, Sergio ^a   May, James M ^a,b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidants; Apolipoprotein E deficiency; Ascorbic acid; Atherosclerosis; Free radicals; Macrophages

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; APOLIPOPROTEIN E; ASCORBIC ACID; CARRIER PROTEINS AND BINDING PROTEINS; CHOLESTEROL; CYCLOOXYGENASE 2; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PROTEIN SVCT2; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; ASCORBIC ACID DEFICIENCY; ATHEROSCLEROSIS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; FEMALE; GENE EXPRESSION; HEMATOPOIETIC CELL; MACROPHAGE; MALE; MITOCHONDRION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEINS E; ASCORBIC ACID; ASCORBIC ACID DEFICIENCY; ATHEROSCLEROSIS; CELLS, CULTURED; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ORGAN SPECIFICITY; ORGANIC ANION TRANSPORTERS, SODIUM-DEPENDENT; SYMPORTERS; TIME FACTORS;

MUS;

EID: 78650697669     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.10.702     Document Type: Article

References (64)

1. R. Ross Atherosclerosis-an inflammatory disease N Engl J. Med. 340 1999 115 126
2. M.F. Linton, and S. Fazio Macrophages, inflammation, and atherosclerosis Int. J. Obes. Relat. Metab. Disord. 27 Suppl. 3 2003 S35 S40
3. N.R. Cook, C.M. Albert, J.M. Gaziano, E. Zaharris, J. MacFadyen, and E. Danielson A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study Arch. Intern. Med. 167 2007 1610 1618
4. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 23 33
5. H.D. Sesso, J.E. Buring, W.G. Christen, T. Kurth, C. Belanger, and J. MacFadyen Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial JAMA 300 2008 2123 2133
6. Y. Terasawa, Z. Ladha, S.W. Leonard, J.D. Morrow, D. Newland, and D. Sanan Increased atherosclerosis in hyperlipidemic mice deficient in α-tocopherol transfer protein and vitamin E Proc. Natl Acad. Sci. USA 97 2000 13830 13834
7. C. Suarna, B.J. Wu, K. Choy, T. Mori, K. Croft, and O. Cynshi Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency Free Radic. Biol. Med. 41 2006 722 730
8. G.C. Willis An experimental study of the intimal ground substance in atherosclerosis Can. Med. Assoc. J. 69 1953 17 22
9. G.C. Willis The reversibility of atherosclerosis Can. Med. Assoc. J. 77 1957 106 108
10. N. Maeda, H. Hagihara, Y. Nakata, S. Hiller, J. Wilder, and R. Reddick Aortic wall damage in mice unable to synthesize ascorbic acid Proc. Natl Acad. Sci. USA 97 2000 841 846
11. Y. Nakata, and N. Maeda Vulnerable atherosclerotic plaque morphology in apolipoprotein E-deficient mice unable to make ascorbic acid Circulation 105 2002 1485 1490
12. V.R. Babaev, L. Li, S. Shah, S. Fazio, M.F. Linton, and J.M. May Combined vitamin C and vitamin E deficiency worsens early atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 30 2010 1751 1757
13. P. Bergsten, G. Amitai, J. Kehrl, K.R. Dhariwal, H.G. Klein, and M. Levine Millimolar concentrations of ascorbic acid in purified human mononuclear leukocytes: depletion and reaccumulation J. Biol. Chem. 265 1990 2584 2587
14. +-dependent l-ascorbic acid transporters Nature 399 1999 70 75
15. J.M. May, L. Li, Z.C. Qu, and J. Huang Ascorbate uptake and antioxidant function in peritoneal macrophages Arch. Biochem. Biophys. 440 2005 165 172
16. S. Sotiriou, S. Gispert, J. Cheng, Y.H. Wang, A. Chen, and S. Hoogstraten-Miller Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival Nat. Med. 8 2002 514 517
17. V.R. Babaev, S. Fazio, L.A. Gleaves, K.J. Carter, C.F. Semenkovich, and M.F. Linton Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo J. Clin. Invest. 103 1999 1697 1705
18. V.R. Babaev, M.B. Patel, C.F. Semenkovich, S. Fazio, and M.F. Linton Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in low density lipoprotein receptor-deficient mice J. Biol. Chem. 275 2000 26293 26299
19. B. Paigen, A. Morrow, P.A. Holmes, D. Mitchell, and R.A. Williams Quantitative assessment of atherosclerotic lesions in mice Atherosclerosis 68 1987 231 240
20. S. Fazio, V.R. Babaev, A.B. Murray, A.H. Hasty, K.J. Carter, and L.A. Gleaves Increased atherosclerosis in mice reconstituted with apolipoprotein E null macrophages Proc. Natl Acad. Sci. USA 94 1997 4647 4652
21. V.R. Babaev, J.D. Chew, L. Ding, S. Davis, M.D. Breyer, and R.M. Breyer Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis Cell Metab. 8 2008 492 501
22. J.M. Vislisel, F.Q. Schafer, and G.R. Buettner A simple and sensitive assay for ascorbate using a plate reader Anal. Biochem. 365 2007 31 39
23. E. Erbay, V.R. Babaev, J.R. Mayers, L. Makowski, K.N. Charles, and M.E. Snitow Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis Nat. Med. 15 2009 1383 1391
24. E. Galkina, and K. Ley Immune and inflammatory mechanisms of atherosclerosis Annu. Rev. Immunol. 27 2009 165 197
25. C.L. Price, and S.C. Knight Advanced glycation: a novel outlook on atherosclerosis Curr. Pharm. Des. 13 2007 3681 3687
26. C.P. Hodgkinson, R.C. Laxton, K. Patel, and S. Ye Advanced glycation end-product of low density lipoprotein activates the toll-like 4 receptor pathway implications for diabetic atherosclerosis Arterioscler. Thromb. Vasc. Biol. 28 2008 2275 2281
27. S.D. Yan, A.M. Schmidt, G.M. Anderson, J. Zhang, J. Brett, and Y.S. Zou Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J. Biol. Chem. 269 1994 9889 9897
28. Bainton D.F. The cells of inflammation: a general view G. Weissman Handbook of Inflammation 1980 Elsevier/North-Holland Biomedical Press Amsterdam 1 25
29. I. Tabas Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency Arterioscler. Thromb. Vasc. Biol. 25 2005 2255 2264
30. S. Han, C.P. Liang, T. DeVries-Seimon, M. Ranalletta, C.L. Welch, and K. Collins-Fletcher Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions Cell Metab. 3 2006 257 266
31. E. Thorp, D. Cui, D.M. Schrijvers, G. Kuriakose, and I. Tabas Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoE-/- mice Arterioscler. Thromb. Vasc. Biol. 28 2008 1421 1428
32. J. Liu, D.P. Thewke, Y.R. Su, M.F. Linton, S. Fazio, and M.S. Sinensky Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice Arterioscler. Thromb. Vasc. Biol. 25 2005 174 179
33. E.L. Gautier, T. Huby, J.L. Witztum, B. Ouzilleau, E.R. Miller, and F. Saint-Charles Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage Circulation 119 2009 1795 1804
34. S. Arai, J.M. Shelton, M. Chen, M.N. Bradley, A. Castrillo, and A.L. Bookout A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development Cell Metab. 1 2005 201 213
35. Z. Wang, B. Liu, P. Wang, X. Dong, C. Fernandez-Hernando, and Z. Li Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice J. Clin. Invest. 118 2008 195 204
36. K. Aoshiba, J. Tamaoki, and A. Nagai Acute cigarette smoke exposure induces apoptosis of alveolar macrophages Am. J. Physiol. Lung Cell. Mol. Physiol. 281 2001 L1392 L1401
37. S. Vandana, S. Ram, M. Ilavazhagan, G.D. Kumar, and P.K. Banerjee Comparative cytoprotective activity of vitamin C, E and beta-carotene against chromium induced oxidative stress in murine macrophages Biomed. Pharmacother. 60 2006 71 76
38. T. Miike, H. Shirahase, H. Jino, K. Kunishiro, M. Kanda, and K. Kurahashi Effects of an anti-oxidative ACAT inhibitor on apoptosis/necrosis and cholesterol accumulation under oxidative stress in THP-1 cell-derived foam cells Life Sci. 82 2008 79 84
39. A. Ichiki, T. Miyazaki, M. Nodera, H. Suzuki, and H. Yanagisawa Ascorbate inhibits apoptosis of Kupffer cells during warm ischemia/reperfusion injury Hepatogastroenterology 55 2008 338 344
40. R. Asmis, and E.S. Wintergerst Dehydroascorbic acid prevents apoptosis induced by oxidized low-density lipoprotein in human monocyte-derived macrophages Eur. J. Biochem. 255 1998 147 155
41. X. Chi, and J.M. May Oxidized lipoprotein induces the macrophage ascorbate transporter (SVCT2): protection by intracellular ascorbate against oxidant stress and apoptosis Arch. Biochem. Biophys. 485 2009 174 182
42. M.C. Vissers, W.G. Lee, and M.B. Hampton Regulation of apoptosis by vitamin C: specific protection of the apoptotic machinery against exposure to chlorinated oxidants J. Biol. Chem. 276 2001 46835 46840
43. L.K. Harris, G.E. Mann, E. Ruiz, S. Mushtaq, and D.S. Leake Ascorbate does not protect macrophages against apoptosis induced by oxidised low density lipoprotein Arch. Biochem. Biophys. 455 2006 68 76
44. D.L. Zhang, D. Su, A. Berczi, A. Vargas, and H. Asard An ascorbate-reducible cytochrome b561 is localized in macrophage lysosomes Biochim. Biophys. Acta 1760 2006 1903 1913 (Pubitemid 44692367)
45. J.M. May, and Z.C. Qu Chelation of intracellular iron enhances endothelial barrier function: a role for vitamin C? Arch. Biochem. Biophys. 500 2010 162 168
46. I.B. Chatterjee, A.K. Majumder, B.K. Nandi, and N. Subramanian Synthesis and some major functions of vitamin C in animals Ann. NY Acad. Sci. 258 1975 24 47
47. O. Arrigoni, and M.C. De Tullio Ascorbic acid: much more than just an antioxidant Biochim. Biophys. Acta, Gen. Subj. 1569 2002 1 9
48. C.J. Rebouche Ascorbic acid and carnitine biosynthesis Am. J. Clin. Nutr. 54 1991 1147S 1152S
49. T. Cramer, Y. Yamanishi, B.E. Clausen, I. Forster, R. Pawlinski, and N. Mackman HIF-1α is essential for myeloid cell-mediated inflammation Cell 112 2003 645 657
50. M. Hirsilä, P. Koivunen, V. Gunzler, K.I. Kivirikko, and J. Myllyharju Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor J. Biol. Chem. 278 2003 30772 30780
51. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus Cell 107 2001 1 3
52. K. Salnikow, and K.S. Kasprzak Ascorbate depletion: a critical step in nickel carcinogenesis? Environ. Health Perspect. 113 2005 577 584
53. M.C. Vissers, S.P. Gunningham, M.J. Morrison, G.U. Dachs, and M.J. Currie Modulation of hypoxia-inducible factor-1α in cultured primary cells by intracellular ascorbate Free Radic. Biol. Med. 42 2007 765 772
54. M.C. Vissers, and R.P. Wilkie Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1α J. Leukoc. Biol. 81 2007 1236 1244
55. S.R. Walmsley, C. Print, N. Farahi, C. Peyssonnaux, R.S. Johnson, and T. Cramer Hypoxia-induced neutrophil survival is mediated by HIF-1α-dependent NF-kappaB activity J. Exp. Med. 201 2005 105 115
56. P. Pichiule, J.C. Chavez, A.M. Schmidt, and S.J. Vannucci Hypoxia-inducible factor-1 mediates neuronal expression of the receptor for advanced glycation end products following hypoxia/ischemia J. Biol. Chem. 282 2007 36330 36340
57. A.M. Schmidt, S.D. Yan, S.F. Yan, and D.M. Stern The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses J. Clin. Invest. 108 2001 949 955
58. E. Harja, D.X. Bu, B.I. Hudson, J.S. Chang, X. Shen, and K. Hallam Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice J. Clin. Invest. 118 2008 183 194
59. L. Sun, T. Ishida, T. Yasuda, Y. Kojima, T. Honjo, and Y. Yamamoto RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice Cardiovasc. Res. 82 2009 371 381
60. R. Kang, D. Tang, N.E. Schapiro, K.M. Livesey, A. Farkas, and P. Loughran The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival Cell Death Differ. 17 2010 666 676
61. X.M. Zhu, Y.M. Yao, H.P. Liang, F. Liu, N. Dong, and Y. Yu Effect of high mobility group box-1 protein on apoptosis of peritoneal macrophages Arch. Biochem. Biophys. 492 2009 54 61
62. M.T. Coughlan, D.R. Thorburn, S.A. Penfold, A. Laskowski, B.E. Harcourt, and K.C. Sourris RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes J. Am. Soc. Nephrol. 20 2009 742 752
63. J. Chen, M. Song, S. Yu, P. Gao, Y. Yu, and H. Wang Advanced glycation endproducts alter functions and promote apoptosis in endothelial progenitor cells through receptor for advanced glycation endproducts mediate overexpression of cell oxidant stress Mol. Cell. Biochem. 335 2010 137 146
64. L.J. Pagliari, H. Perlman, H. Liu, and R.M. Pope Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis Mol. Cell. Biol. 20 2000 8855 8865